The anti-factor D antibody, MAb 166-32, inhibits the alternative pathway of the human complement system.
暂无分享，去创建一个
B. Lucchesi | K. L. Murphy | K. Kilgore | M. Fung | E. J. Tanhehco | C. Sun | W. Sun | D. A. Liff | D. Liff | K.S Kilgore | D.A Liff | K.L Murphy | M.S Fung | W.N Sun | B.R Lucchesi
[1] J. Platt,et al. Recent advances in the immunology of xenotransplantation , 1997, Immunologic research.
[2] B. Lucchesi,et al. Selective inhibition of the alternative complement pathway by sCR1[desLHR-A] protects the rabbit isolated heart from human complement-mediated damage. , 1996, Immunopharmacology.
[3] J. Platt,et al. The barrier to xenotransplantation. , 1991, Transplantation.
[4] D. White,et al. Hyperacute rejection of xenografts in the complete absence of antibody. , 1991, Transplantation proceedings.
[5] F. Spertini,et al. A monoclonal antibody which blocks the function of factor D of human complement. , 1990, Journal of immunological methods.
[6] J. Volanakis. Participation of C3 and its ligands in complement activation. , 1990, Current topics in microbiology and immunology.
[7] L. Truedsson,et al. Influence of factor D concentrations on fluid phase C3 activation, lysis of rabbit erythrocytes and solubilization of immune complexes. , 1989, Immunology letters.
[8] J. Kearney,et al. Quantitation of complement factor D in human serum by a solid-phase radioimmunoassay. , 1984, JIM - Journal of Immunological Methods.
[9] H. Müller-Eberhard,et al. Mechanism of action of factor D of the alternative complement pathway , 1978, The Journal of experimental medicine.
[10] R. Varco,et al. ROLE OF THE COMPLEMENT SYSTEM IN GRAFT REJECTIONS IN EXPERIMENTAL ANIMALS AND MAN * , 1966 .